acetylcarnitine has been researched along with Infant, Newborn, Diseases in 1 studies
Acetylcarnitine: An acetic acid ester of CARNITINE that facilitates movement of ACETYL COA into the matrices of mammalian MITOCHONDRIA during the oxidation of FATTY ACIDS.
Infant, Newborn, Diseases: Diseases of newborn infants present at birth (congenital) or developing within the first month of birth. It does not include hereditary diseases not manifesting at birth or within the first 30 days of life nor does it include inborn errors of metabolism. Both HEREDITARY DISEASES and METABOLISM, INBORN ERRORS are available as general concepts.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Xu, S | 1 |
| Waddell, J | 1 |
| Zhu, W | 1 |
| Shi, D | 1 |
| Marshall, AD | 1 |
| McKenna, MC | 1 |
| Gullapalli, RP | 1 |
1 other study available for acetylcarnitine and Infant, Newborn, Diseases
| Article | Year |
|---|---|
In vivo longitudinal proton magnetic resonance spectroscopy on neonatal hypoxic-ischemic rat brain injury: Neuroprotective effects of acetyl-L-carnitine.
Topics: Acetylcarnitine; Animals; Creatine; Drug Monitoring; Female; Humans; Hypoxia-Ischemia, Brain; Infant | 2015 |